发明名称 Process for the preparation of a pharmaceutical composition comprising ezetimibe
摘要 The present invention belongs to the field of pharmaceutical industry and relates to a process for preparing dosage forms containing ezetimibe, comprising the steps of: a) providing a composition comprising ezetimibe,b) sieving a composition comprising a composition of step (a),c) shear mixing of the composition after step (b), preferably the mixing of the composition is carried out by high shear mixing,d) formulation into a dosage form.;The present invention also relates to dosage forms containing ezetimibe and ezetimibe and simvastatin, which have been prepared according to the process according to the invention.
申请公布号 US9089486(B2) 申请公布日期 2015.07.28
申请号 US201013147956 申请日期 2010.02.05
申请人 LEK PHARMACEUTICALS D.D. 发明人 Kerc Janez;Homar Miha;Jurkovic Polona
分类号 A61K9/14;A61K9/20;A61K31/366;A61K31/397;A61P3/06 主分类号 A61K9/14
代理机构 Arent Fox LLP 代理人 Arent Fox LLP
主权项 1. A process for preparing a dosage form, the process consisting essentially of the steps: (a) providing a starting composition of particulates of ezetimibe and a hydrophilic excipient, (b) sieving a composition provided by step (a), (c) high shear mixing of the composition after step (b), and (d) formulation into a dosage form by direct compression, wherein said high shear mixing is carried out at a paddle speed of at least 100 RPM; wherein step (b) occurs before step (c); wherein the size of the particles d (0.9) of ezetimibe in the starting composition is between 8 and 25 μm and is essentially unchanged during the process; wherein the process is conducted under dry conditions without a solvent; wherein after (c) no further ingredients are added and no further mixing or sieving is performed; and wherein, when the produced dosage form is analyzed in a USP Apparatus 2 (paddles) in 0.01 M HCl and 0.25% sodium lauryl sulfate, more than 50% dissolves within 15 minutes.
地址 Ljubljana SI